Diabetic Retinopathy

Over time, high blood sugars can cause damage to retinal vessels and vision loss from diabetic retinopathy.

What is Diabetes Mellitus?

Diabetes is commonly known as elevated blood sugar. It occurs in young people who have trouble producing a substance called insulin that regulates blood sugar, as well as in older people who develop resistance to insulin as they age. Young diabetics are often referred to as Type 1, while older diabetics are ofte referred to as Type 2. There are also some diabetics who exhibit characteristics of both Type 1 and Type 2 diabetes. All types of diabetics suffer similar effects of elevated blood sugar.
When diabetes is uncontrolled it damages blood vessels throughout the body. The longer a person is diabetic and the more poorly the blood sugar levels are controlled, the more likely that person is to suffer blood vessel damage. As diabetes worsens, it first affects the smallest blood vessels, called capillaries, throughout the body. Some of the locations in the body where tiny capillaries are the most important include the kidneys, the nerves in the legs, feet, and hands, and in the light-sensing tissue of the eye called the retina.

What is Diabetic Retinopathy?

The earliest sign of small blood vessel damage in the retina is background diabetic retinopathy, also known as non-proliferative diabetic retinopathy. Background diabetic retinopathy occurs as small blood vessel disease becomes visible in the retina, and your eye doctor can see small aneurysms or hemorrhages (also known as "blood spots") in the retinal tissue at this stage. Most diabetics with background diabetic retinopathy do not know that they have this sign of advancing diabetes, since it does not always affect the vision when it is mildly or moderately severe. However, early detection of background diabetic retinopathy is crucial, as it helps the patient's primary care doctor or endocrinologist (diabetic disease specialist) know the status of the diabetic blood vessel damage throughout the body. The diagnosis of background diabetic retinopathy also lets the patient's eye doctor know that the patient is at a higher risk of vision loss than a patient without background diabetic retinopathy. The guidelines of the American Diabetes Association and American Academy of Ophthalmology reflect that all diabetics should have a dilated eye exam regularly in an effort to detect background diabetic retinopathy while it is still in its early stages.

What is a Diabetic Eye Examination?

When a patient comes to the retinal office for a diabetic eye exam, there are sometimes special imaging tests recommended by the doctor in addition to the dilated eye exam. These tests can include specific pictures of the eye with both regular color digital cameras and special laser cameras. Retinal tomography, or an evaluation of the retinal thickness and the retinal layers, is a unique technology often used to assess the structure and health of the diabetic retina. Fluorescein angiography is another specialized imaging test that allows for detailed visualization of the tiny retinal blood vessels as well as leakage from areas that are diseased. Sometimes an ultrasonic picture of the back of the eye is obtained. During your visit, your doctor will decide which of these tests are important for assessment of the retina. Not every test is recommended at every visit.

What can I do to Preserve Vision?

The cornerstone of saving vision in diabetes remains excellent blood sugar control. Over the last 2 generations, there has been ample, repeated evidence that keeping the blood sugar at an appropriate level, controlling blood pressure, and monitoring cholesterol and fats in the blood are the most effective ways to stave off diabetic retinopathy. It is very important that every diabetic has a good relationship with their primary care team and makes every effort to optimize their diabetic health. A healthy diet, regular exercise several times each week, routine at-home blood sugar monitoring as directed by your diabetic doctor, and ongoing compliance with diabetic medications are the most important part of saving vision in diabetes.

What is Background Diabetic Retinopathy?

If diabetes remains poorly controlled, background diabetic retinopathy advances as there is more and more small blood vessel damage. The small blood vessels continue to collapse and result is varying degrees of retinal ischemia, or poor blood flow to the retinal tissue due to the absence of normal blood vessel supply. Essentially, progressing diabetic retinopathy is like placing a tourniquet on the retina a slowly tightening it. There is currently no technology to restore the lost blood vessels. The lack of these blood vessels itself can cause irreversible vision loss and often limits the vision in diabetics.

What is Diabetic Macular Edema?

, There are two treatable processes that occur as there is less and less normal retinal blood flow. The first is called diabetic macular edema, which means swelling in the retina associated with diabetes. This swelling can blur and distort the vision. The swelling occurs because the walls of the small blood vessels are progressively more damaged in diabetes, and there is leakage of blood and fluid into the cells of the retina.

Read more

What is Proliferative Diabetic Retinopathy?

The second treatable process in diabetic retinopathy is the growth of abnormal new blood vessels in the eye. This process is called proliferative retinopathy. The abnormal new blood vessels in the eye probably appear in response to progressive absence of normal blood vessels, and this is an even more ominous process than diabetic macular edema. Often there is both diabetic macular edema and proliferative diabetic retinopathy in the same patient at the same time. The abnormal new blood vessels seen in proliferative retinopathy are fragile and often will bleed into the vitreous jelly filling the back of the eye. This process is called vitreous hemorrhage, and patients will often see hundreds of spots, swirls, or lines when vitreous hemorrhage begins. Sometimes the hemorrhage can be so dense that there is severe blurring of vision. As the abnormal new blood vessels continue to grow, they get denser and thicker. This process can lead to tugging or traction on the retina, and that is termed a diabetic tractional retinal detachment. Diabetic retinal detachment is the most serious and advanced stage of diabetic retinopathy. Abnormal new blood vessel growth in the eye can be treated in its earlier stages with laser therapy. The laser technique is much different than that applied to diabetic macular edema.

Read more

What is a Vitreous Hemorrhage?

Patients with diabetes develop weak blood vessels in the retina that are prone to bleeding. If bleeding occurs into the vitreous cavity, patients will see many tiny floaters and develop moderate to severe vision loss. The blood inside the eye doesn't harm the eye but it does block the vision. Blood inside the eye will sometimes absorb within a few weeks or months. When the blood absorb the vision improves. If the blood doesn't asborb, vitrecotmy surgery can be performed to improve the vision. Because of the risk of surgery, most surgeons wait anywhwere from one month to 6 months depending on the situation to see if the blood will clear without surgery.

Read more

What is a Diabetic Tractional Retinal Detachment?

Patients with proliferative diabetic retinopathy sometimes develop a tractional retinal detachment. This can occur when scar tissue grows on the surface of the retina and then contracts or is pulled forwward in the eye by the vitreous. When this happens, the retina, which is stuck to the diabetic scar tissue, pulls away from the back of the eye and away from its blood supply. The vision declines and the retina suffers. Tractional retinal detachments can usually be prevented if sufficient pan-retinal laser is administered before the scar tissue progresses. Once there is a tractional retinal detachment surgery can be helpful.

Read more

Diabetic Retinopathy NEWS

Below are current articles from a Google News Feed on Diabetic Retinopathy

  1. Aerpio Shares Plummet after Lead Candidate Fails Phase IIb Diabetic Retinopathy Trial  Genetic Engineering & Biotechnology News
  2. Aerpio Pharmaceuticals Study for Diabetic Retinopathy Does Not Meet Endpoints  dLife.com
  3. Aerpio shares tumble as lead eye drug trips up in mid-stage diabetic retinopathy study  Endpoints News
  4. Aerpio Asset AKB-9778 Fails to Hit Endpoints in Phase IIb Diabetic Retinopathy Trial  BioSpace
  5. Aerpio Pharmaceuticals stock plummets after failed trial of diabetic retinopathy treatment  MarketWatch
  6. View full coverage on Google News
Potential diabetic retinopathy treatment fails to meet phase 2b study endpoint  Healio

A treatment candidate for moderate to severe nonproliferative diabetic retinopathy failed to meet its phase 2b study primary endpoint, according to a press ...

Disease Pathways for Diabetic Retinopathy Vary Between Patients  Endocrinology Network

Diabetic retinopathy is the leading cause of blindness among working adults in the United States, but disease pathways may vary between patients according to ...

Clinician-AI combination is best in diagnosing diabetic retinopathy  Health Data Management

Assisted by a deep-learning algorithm, physicians were able to more accurately diagnose diabetic retinopathy—a potentially blinding eye disease—than either a ...

Patient, systemic barriers impede follow-up for diabetic retinopathy  Healio

Patients who did not attend follow-up appointments for their diabetic retinopathy were more likely to have other medical conditions or to forget they have an ...

Angiogenesis expert: ODs play vital role in diabetic retinopathy management  Healio

NEW ORLEANS – “In the ecosystem of diabetes care, the optometry community is on the front lines for basic, fundamental eye care,” William W. Li, MD, said at ...

Google, Verily using AI to screen for diabetic retinopathy in India  Healthcare IT News

The machine learning algorithm can also help with screening for diabetic macular edema, a boon for patients in a country where physicians are in short supply.

Link between high HDL cholesterol and diabetic retinopathy | Diabetes Research and Clinical Practice  MD Linx

Ophthalmology Article: High HDL cholesterol: A risk factor for diabetic retinopathy? Findings from NO BLIND study.

Google launches India program to screen diabetics for eye conditions that can cause blindness  CNBC

Google and Verily teamed up to develop a screening tool for conditions that can cause preventable eye disease in adults. It is now being used at an eye hospital ...

TIME-2b Disappointed: Aerpio's Lead Product Fails In Diabetic Retinopathy  Scrip

As its lead product fails at Phase IIb in diabetic retinopathy, Aerpio's attentions turn to its other potential indications, but investors will need more convincing that ...

Eye doctors using AI beat unassisted docs, AI alone at diagnosing diabetic vision loss  Health Imaging

Google's AI research group has shown that deep-learning algorithms can fine-tune ophthalmologists' diagnosis of diabetic retinopathy on retinal fundus ...

Red spot on eye: Causes and treatment  Medical News Today

A red spot on the eye is usually a subconjunctival hemorrhage that will heal over time without treatment. It can also be due to diabetes complications.

NPDR Drug Trial Shows Positive Results  Pharmacy Times

Positive 1 year results from the Phase 3 PANORAMA trial evaluating Regeneron Pharmaceuticals' aflibercept injection (Eyelea) in patients with moderately ...

India Fights Diabetic Blindness With Help From A.I.  The New York Times

A partnership with Google is part of a global effort to build and deploy systems that can detect signs of illness and disease in medical scans.

Diabetic Retinopathy Predicts Higher CKD Progression Risk  Renal and Urology News

Diabetic retinopathy in patients with chronic kidney disease (CKD) is associated with an increased risk of CKD progression, according to a new study. “Routine ...

Google, Verily use machine learning to detect diabetic eye disease  FierceHealthcare

Physicians at Aravind Eye Hospital in Madurai, India, are using a machine learning-enabled tool developed by Verily and Google to screen for diabetic ...

Deep Learning-Enhanced Device Detects Diabetic Retinopathy  Medical Bag

Compared with the reference standard, the hybrid deep learning-enhanced device's sensitivity/specificity was 100/97.8% for vision-threatening diabetic ...

Diabetic Retinal Screening  Knoe.com

MONROE, La (KNOE) - What is the diabetic retinal screening? A diabetic retinal screening is an eye exam, performed on patients who have been diagnosed ...

Global Proliferative Diabetic Retinopathy Market 2019 Intas Pharmaceuticals, Santen Pharmaceutical  Industry News Daily

The report on the Global Proliferative Diabetic Retinopathy Market offers complete data on the Proliferative Diabetic Retinopathy market. Components, for ...

Artificial intelligence and medicine: Is it overhyped?  Medical Design & Outsourcing

Artificial intelligence raises exciting possibilities for healthcare, but are companies promising more than they can deliver?

UVA Health System Expanding Telehealth to Better Treat Diabetes, Heart Disease  UVA Today

The University of Virginia Health System is expanding its telehealth capacity to help patients across Virginia better prevent or manage chronic conditions that ...

Race/Ethnicity and glycemic thresholds to predict diabetic retinopathy | JAMA Ophthalmology  MD Linx

Internal Medicine Article: Association of race/ethnicity with specific glycemic thresholds for predicting diabetic retinopathy.

India to soon get an algorithm to detect diabetic eye conditions  The News Minute

The collaborative project between is Google and its sister company Verily is an an algorithm, designed to screen medical imaging for two diabetes-related ...

Google, Verily develop AI algorithm to detect diabetic eye disease from imaging exams  Health Imaging

Google and its sister company Verily announced on Monday, Feb. 25, the development of an AI-based algorithm that can screen eye imaging exams for diabetic ...

Optical coherence tomography angiography for diabetic retinopathy | Acta Ophthalmologica  MD Linx

Internal Medicine Article: Quantitative analysis of retinal and choroid capillary ischaemia using optical coherence tomography angiography in type 2 diabetes.

Alimera Sciences (ALIM) Reports Approval of ILUVIEN in Kuwait  StreetInsider.com

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Diabetic Retinopathy Market detailed information about segmentation and latest trends.  Industrial News

Global Diabetic Retinopathy Market 2019 is an in depth, skilled analysis conveyance Diabetic Retinopathy marketing research information that is pertinent to ...

North America Self-monitoring Blood Glucose Market to 2024: Market is Expected to Witness a CAGR of 13.44%  Benzinga

DUBLIN, March 22, 2019 /PRNewswire/ -- The "North America Self-monitoring Blood Glucose Market - Growth, Trends, and Forecast (2019 - 2024)" report has ...

Global Proliferative Diabetic Retinopathy Therapeutics Market 2019 – Acucela Inc, Aerie Pharmaceuticals Inc, Antisense Therapeutics Ltd, Icon Bioscience Inc  MajoReports

The comprehensive analysis of Global Proliferative Diabetic Retinopathy Therapeutics Market provides up-to-date product knowledge, industry growth curve, ...

Global Diabetic Retinopathy Market Product Definition, Demand, Growth, and Forecast 2019-2024  Global Industry Journal

Market Research Explore recently published Global Diabetic Retinopathy Market Research Report 2019 Concentrates On Restraints, Reimbursement Policies, ...

How to improve and protect eyesight naturally: 11 ways  Medical News Today

There are many natural ways a person can help protect and improve their eyesight without the need for corrective glasses. This can include simple things such ...

India- Global Diabetic Retinopathy Market Size is expected to grow at a CAGR of 5.2% By 2023  MENAFN.COM

(MENAFN - GetNews) MRFR provides analysis of Global Diabetic Retinopathy Market Size, Share, Opportunities, Scope, Industry Analysis, Products, Applic.

HbA1c promising as predictive measure for cystic fibrosis-related diabetes  Healio

Adults with cystic fibrosis and HbA1c levels of 37 mmol/mol or more are at greater risk for dysglycemia and cystic fibrosis-related diabetes than those with lower ...

With new rules in place, FMCSA rescinds diabetes exemption for commercial drivers  American Trucker

FMCSA withdrew exemptions processes set up in 2003 and 2005 for individuals with insulin-treated diabetes mellitus to be medically certified to operate CMVs.

Deep learning algorithm shows promise for predicting RA outcomes  medwireNews

Deep learning models based on electronic health records may be a feasible approach for predicting rheumatoid arthritis outcomes.

Global Diabetic Retinopathy Market Insight Report 2019 – ICo Therapeutics, Sirnaomics, BCN Peptides, OPKO Health, Boehringer Ingelheim  WDC News Updates

The global “Diabetic Retinopathy” market research report comprises the description of all the important points concerning the Diabetic Retinopathy market.

Andrew Yang pitches dividend to Iowa Democrats, tech entrepreneurs  Iowa City Press Citizen

Universal health care. Free college. A chicken in every pot. Campaign promises are nothing new. But $1,000 per month for every adult citizen — that is causing ...

How Artificial Intelligence is Already Changing Medicine  TIME

Artificial intelligence (AI) is infiltrating everything, from the way we shop to medical care we get. Here's the latest on AI and medicine.

North America Self-Monitoring Blood Glucose (Glucometer Devices, Test Strips, and Lancets) Market Forecast to 2024  GlobeNewswire

Dublin, March 22, 2019 (GLOBE NEWSWIRE) -- The "North America Self-monitoring Blood Glucose Market - Growth, Trends, and Forecast (2019 - 2024)" report ...

Delayed menarche heightens overt nephropathy risk in type 1 diabetes  Healio

Overt nephropathy is more likely to develop in women with type 1 diabetes who are older at age of menarche compared with those who are younger, according ...

Intravitreal (IVT) Injectables Market is Expected to Rake in Revenues Worth US$ 4,350 Mn by 2028 End  PRNewswire

NEW YORK, March 14, 2019 /PRNewswire/ -- Hereditary retinal diseases is the major cause of visual loss. Macular degeneration, Diabetic Retinopathy is the ...

West Virginia Doctor Recognized for Service to Poor in India  U.S. News & World Report

MORGANTOWN, W.Va. (AP) — Dr. V.K. Raju, the Morgantown ophthalmologist, is best described as working in a blur.

Diagnostic Efficacy and Therapeutic Decision-making Capacity of an Artificial Intelligence Platform for Childhood Cataracts in Eye Clinics: A Multicentre Randomized Controlled Trial  The Lancet

CC-Cruiser is an artificial intelligence (AI) platform developed for diagnosing childhood cataracts and providing risk stratification and treatment ...

Diabetic Retinopathy Treatment Market Survey and Forecast Report 2019| Regeneron Pharmaceuticals, ThromboGenics, Genentech, Bayer Healthcare  Review Health World

Los Angeles, United State, Mar 7, 2019– The report presented here is a comprehensive research study that explores key aspects of the global Diabetic ...

Google, Verily Develop Tech To Identify Diabetic Retinopathy, Macular Edema  ZMR News Magazine

A Google research effort which is being considered as one of its highly promising efforts, has finally found its way out from the laboratory into the public eye.

Aerpio Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Update  BioSpace

Top-Line Results from the TIME-2b Clinical Trial Evaluating the Effect of AKB-9778 in Patients with Non-Proliferative Diabetic Retinopathy (NPDR) Expected in ...

Oxurion NV to Present Preclinical Evaluation of Plasma Kallikrein Inhibition for DME at 2019 EURETINA Winter Meeting  BioSpace

Published: Feb 28, 2019. Leuven, Belgium, 28 February 2019 – Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company developing innovative ...

Using Glycemic Variability To Predict Major Cardiac Events In Type 2  Diabetes In Control

Too many highs and lows in glucose levels could be another reason that causes cardiovascular complications. Dysglycemia is an abnormality that leads to ...

Global Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Intelligence Report for Comprehensive Information 2019-2024  World Gazette

The Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs market globally is the most encouraging markets. This global market is evolving with a ...

Statins May Prevent Diabetic Retinopathy in People with Diabetes  EndocrineWeb

Individuals with diabetes who were taking a statin for high blood cholesterol have the added benefit of reducing their risk of developing diabetic retinopathy, and ...

Diet Soda Linked to Increased Risk for Diabetic Retinopathy  Medscape

Diet soda, but not regular soda, was linked to increased risk for proliferative diabetic retinopathy, a study found; further studies are needed to confirm these ...

Proliferative Diabetic Retinopathy Market Research 2018-2023 : Analysis Of Key Players ,Potential Growth, Share, Demand And Forecast  Rochester Leader

Proliferative Diabetic Retinopathy Market Report Provide Analysis of Proliferative Diabetic Retinopathy industry on the basis of Current Market trends, Product ...

Diet Soda Associated with Increased Risk for Diabetic Retinopathy, Study  dLife.com

New findings show that drinking diet soda may increase the risk for proliferative diabetic retinopathy (PDR), a severe type of diabetic eye disease, according to ...

Photos: Andrew Yang visits IDx Technologies Inc. in Coralville  Iowa City Press Citizen

See photos from a visit 2020 presidential candidate Andrew Yang had March 13, 2019, at IDx Technologies Inc. in Coralville, Iowa.

FDA Clears AI Device for Diabetic Retinopathy Diagnosis  DARKDaily.com - Laboratory News

FDA clearance of an AI system for diagnosing diabetic retinopathy using retinal images shows medical potential of deep learning and algorithmic analysis.

Diabetic Retinopathy Programme Continues  St. Lucia Times Online News

Press Release:- A team from the Queen Elizabeth Diamond Jubilee Trust recently visited Saint Lucia to review the work undertaken through the Diabetic.

Retinal Biologics Market to Hold at 11.1% CAGR through 2028  dailychronicle24.com

Retinal biologics market value surpassed US$ 14.6 billion in 2018 and projected to grow at 10.7% y-o-y in 2019, as per a new FMI study. The projected growth ...

Statins Cut Retinopathy Risk in Type 2 Diabetes  MedPage Today

Treatment with statins was associated with a significantly decreased risk of diabetic retinopathy in patients with type 2 diabetes and high cholesterol in a large ...

How The Body Of The Future Adapts Old World Techniques For A New Era  UPROXX

In 2009, the now-retired runner Usain Bolt ran the 100 meters in 9.58 seconds, blowing away the previous world record (which he owned, having set it twice in ...

Anti-VEGF injections may play increasing role in treatment of diabetic retinopathy  Healio

Ocular Surgery News | Patients with diabetic macular edema and moderately severe to severe nonproliferative diabetic retinopathy, as determined on the ...

Reducing Diabetes Complications in Tillamook County: RetinaVue Screening Technology Donated by Adventist Health  Tillamook County Pioneer

Adventist Health Tillamook has taken a new step to reduce the risk of diabetic complications in Tillamook County. The Rinehart Clinic and Tillamook County ...

More Diabetic Retinopathy Screening? Primary Care May Be the Answer  MedPage Today

Primary care may be an untapped resource for diabetic retinopathy screening, a new study suggested. In a survey of over 3,200 adults with diabetes, nearly 88% ...

AI Supports Diagnosis of Diabetic Retinopathy  Technology Networks

Technology Networks is an internationally recognised publisher that provides access to the latest scientific news, products, research, videos and posters.

Statin Therapy Reduces Risk for Diabetic Retinopathy in Type 2 Diabetes  The Cardiology Advisor

HealthDay News – For Taiwanese patients with type 2 diabetes and dyslipidemia, statin therapy is associated with a reduced risk for diabetic retinopathy, ...

Diabetic Retinopathy Treatment Market Research Report 2018 | Business Overview, Product Specification and Top Manufactures  National News Times

Diabetic retinopathy, also known as diabetic eye disease, is a common retinal complication that arises in diabetic patients due to the damage caused to the ...

Gift restores sight to Michigan boy injured in fishing accident  WDIV ClickOnDetroit

It was a freak fishing accident that left a young boy virtually blind in one eye. But a special gift changed everything.

Diet soda consumption associated with increased risk of diabetic retinopathy  Healio

Researchers found that patients with diabetes who consumed more than four cans per week of a diet soft drink had a more-than-twofold risk of having ...

Diabetic retinopathy position statement promotes prevention, early detection, control  Healio

A new position statement by the American Diabetes Association recommends intensive glycemic control and regular screening for prevention and early ...

Diabetic retinopathy linked to glycemic variability in type 2 diabetes  Healio

Glycemic variability is more strongly associated with diabetic retinopathy in adults with type 2 diabetes than in those with latent autoimmune diabetes in adults, ...

Macular Edema Treatment Market Archives  TechnoBleak

Macular Edema Treatment Market 2018 Opportunities, Competition from Opponents, Dynamics, Demand, Challenge and Risk and Forecast to 2026.

New Retinal Scanner Helps Diagnose Diabetic Retinopathy  The Parsons Advocate

ELKINS, W.Va. – A new technology at Davis Medical Center (DMC) is designed to help those with diabetes detect diabetic retinopathy in its early stages and ...

Statins May Reduce Risk of Retinopathy in Diabetes Patients  MD Magazine

Statins are already a common therapy among patients with type 2 diabetes. Its cholesterol-lowering benefits may help retain patient vision longer.

FDA to Review Injection Treatment for Diabetic Retinopathy  Pharmacy Times

The FDA has accepted for review Regeneron Pharmaceuticals' supplemental Biologics License Application (sBLA) of aflibercept (EYLEA Injection) to treat ...

Diabetic Retinopathy Market Segmented by – Current Scenario, Future Growth Analysis and Forecast 2025  National News Times

This Report analyze current as well as future aspects of the Diabetic Retinopathy Industry. The Diabetic Retinopathy Market provides demand, trends and ...

Two Treatments, Similar Outcomes in Diabetic Retinopathy  MedPage Today

Two different approaches to treating proliferative diabetic retinopathy (PDR) led to similar improvement in visual acuity at 5 years, results of a randomized trial ...

Don't Let Diabetic Eye Disease Sneak Up on You  University of Utah Health Care

Nov 14, 2018 12:00 AM. If you are one of the 30.3 million Americans with diabetes, you are at risk for diabetic eye disease—including blindness.

ICO Publishes New Guidelines for Diabetic Retinopathy  MD Magazine

Importantly, they are not directed toward ophthalmologists, but at general physicians and public healthcare professionals.

IRIDEX (IRIX) Upgraded to Hold by Zacks Investment Research  Fairfield Current

Zacks Investment Research upgraded shares of IRIDEX (NASDAQ:IRIX) from a sell rating to a hold rating in a research note issued to investors on Thursday.

Considering Three Major Developments in the Diabetes Retinopathy Industry  MD Magazine

The DR market is expected to accrue a sum of $2490 million by 2022, growing at a compound annual growth rate of 14.4% from 2014-2022.

Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market xperience Major Revenue Boost during the Period between 2015-2021 | Kentucky Breaking News Updates  Kentucky Journal 24

Age related macular degeneration (AMD) is a medical condition that results in loss of vision in the central visual field, owing to damage to the retina. This is ...

Aflibercept Benefits Bevacizumab-Unresponsive Diabetic Retinopathy Patients  MD Magazine

A new analysis of an ongoing clinical study offers insights for treating retinal vein occlusion in poor responders to bevacizumab.

Prince Charles hails pop star Rihanna as global style icon and 'one of the most influential recording artists of her generation'  Evening Standard

Prince Charles hailed singer Rihanna as a "global style icon" but admitted he finds it tough keeping up with the latest pop stars and has to rely on Prince Harry to ...

Global Proliferative Diabetic Retinopathy Market 2019 Industry Development and Growth Forecast to 2025  Buffalo Morning Star

Global Proliferative Diabetic Retinopathy Market Research Report 2018 from MarketAndResearch.biz offers a comprehensive study including company's ...

Diabetic Retinopathy Treatment Market Analysis On Industry Growth In 2019 By: Pfizer, Bayer, Novartis, Roche, Oxurion NV, Regeneron Pharmaceuticals, Inc., Allergan,  Wise Awareness

Diabetic Retinopathy Treatment Market report is a complete overview of the market, covering various aspects product, segmentation based on various ...

Proliferative diabetic retinopathy revealed using OCT angiography  Healio

Primary Care Optometry News | Diabetic retinopathy is one of the leading causes of vision loss worldwide. Uncontrolled blood glucose levels damage retinal ...

Different risk factors predict diabetic retinopathy, nephropathy in type 2 diabetes  Healio

Progression of diabetic retinopathy is associated with increased HbA1c, whereas risk factors for diabetic nephropathy include HbA1c variability and dyslipidemia ...

Agreement seen between ultra-widefield, ETDRS images for grading diabetic retinopathy severity  Healio

Ultra-widefield imaging was found to have “moderate to substantial agreement” with ETDRS 7-field imaging to determine the severity of diabetic retinopathy.

Regeneron and Roche Duke It out in the Diabetic Retinopathy Market  BioSpace

Regeneron Pharmaceuticals' Eylea (aflibercept) showed strongly positive data in a Phase III trial in patients with moderately severe and severe non-proliferative ...

Statins, Fibrates Lower Diabetic Retinopathy Risks in Diabetes  Medscape

The use of lipid-lowering medication with fibrates, including fenofibrate (Lipidil, Abbott), and statins reduces not only the incidence of diabetic retinopathy in ...

Lipid‐Lowering Medication Decreases Risk of Diabetic Retinopathy in Type 2 Diabetes  dLife.com

Using lipid-lowering medication with fibrates, including fenofibrate and statins reduces not only the incidence of diabetic retinopathy in patients with Type 2 ...

AI system can detect diabetic retinopathy  UPI.com

Researchers developed a system that uses artificial intelligence to successfully detect diabetic retinopathy, according to a trial in primary care offices.

Benefits with Early Treatment of Diabetic Retinopathy  MedPage Today

VANCOUVER -- Almost 60% of patients with nonproliferative diabetic retinopathy (NPDR) had at least a two-step improvement in retinopathy score when treated ...

Statin therapy reduces risk for diabetic retinopathy in T2DM  Medical Xpress

(HealthDay)—For Taiwanese patients with type 2 diabetes and dyslipidemia, statin therapy is associated with a reduced risk for diabetic retinopathy, according ...

Diabetic Retinopathy Market Challenges with Forecast to 2028 : Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications  Tech News Store

Global Diabetic Retinopathy Market Analysis, Size, Share, Outlook and Forecast to 2019-2028 is a professional and in-depth research report on the world's ...

One-Year Results from Positive Phase 3 EYLEA Trial in Diabetic Retinopathy Presented at Angiogenesis Symposium  BioSpace

Published: Feb 09, 2019. TARRYTOWN, N.Y., Feb. 9, 2019 /PRNewswire/ --. Trial showed that early intervention with EYLEA improved diabetic retinopathy ...

Analysis of Patient-Reported Barriers to Diabetic Retinopathy Follow-Up  Healio

Ophthalmic Surgery, Lasers and Imaging Retina | BACKGROUND AND OBJECTIVES:Close follow-up of diabetic retinopathy (DR) has been linked to improved ...

venBio Select Advisor LLC Acquires Shares of 902,200 Kodiak Sciences Inc. (NYSE:KOD)  Fairfield Current

venBio Select Advisor LLC acquired a new stake in shares of Kodiak Sciences Inc. (NYSE:KOD) in the 4th quarter, according to the company in its most recent ...

Aerpio Pharmaceuticals Announces Completion of Patient Dosing in TIME-2b Study of AKB-9778 in Diabetic Retinopathy  BioSpace

CINCINNATI--(BUSINESS WIRE)-- Aerpio Pharmaceuticals, Inc. (Nasdaq: ARPO), a biopharmaceutical company focused on developing compounds that ...

Diabetic Eye Exams: Why They Matter  Contemporary Clinic

Diabetes can result in vision problems, so it is important to closely monitor patients through comprehensive eye examinations. Unfortunately, diabetic eye ...

Diet Soda Linked to Risk for Diabetic Blindness  WebMD

Jan. 8, 2019 -- Drinking diet soda may raise the risk for a severe type of diabetic eye disease that can lead to blindness, a new study says. The study, published ...

» Load more

What about Resources?

Dr. Pautler's Blog

This site is not designed to and does not provide medical advice, professional diagnosis, opinion, treatment or services to you or to any other individual. Through this site and linkages to other sites, The information provided in this site, or through linkages to other sites, is not a substitute for medical or professional care, and you should not use the information in place of a visit, call consultation or the advice of your physician or other healthcare provider.

IF YOU BELIEVE YOU HAVE A MEDICAL EMERGENCY, YOU SHOULD IMMEDIATELY CALL 911 OR YOUR PHYSICIAN. If you believe you have any other health problem, or if you have any questions regarding your health or a medical condition, you should promptly consult your physician or other healthcare provider. Never disregard medical or professional advice, or delay seeking it, because of something you read on this site or a linked website. Never rely on information on this website in place of seeking professional medical advice. You should also ask your physician or other healthcare provider to assist you in interpreting any information in this Site or in the linked websites, or in applying the information to your individual case.

Medical information changes constantly. Therefore the information on this Site or on the linked websites should not be considered current, complete or exhaustive, nor should you rely on such information to recommend a course of treatment for you or any other individual. Reliance on any information provided on this Site or any linked websites is solely at your own risk.